Text size Jeenah Moon / Getty Images Pfizer hopes to get emergency food authorization from the Food and Drug Administration for its Covid-19 vaccine, produced in collaboration with BioNTech, in October – a timeline that is possible, and not the only positive for the biotech industry, according to a Mizuho …
Read More »Potential Gilead blockbusters rejected by FDA. Why that’s the ‘Near-Worst-Case Scenario’ for Gilead Stock.
Text size The Food and Drug Administration on Tuesday rejected Gilead Science’s application for a will-be blockbuster arthritis medicine, blind investors. One analyst called the development a ‘near-worst-case scenario’ and a ‘shock’. Dreamstime The Food and Drug Administration’s decision to deny Gilead Science’s application for a wild medicine for blockbuster …
Read More »Gilead announces another cancer campaign
Shares of Gilead Sciences Inc. VALID, -0.09% won 0.3% in premarket trading on Tuesday after the drugmaker announced a deal worth more than $ 6 billion with Tango Therapeutics on Monday night. The collaboration, which began in 2018, has been expanded to allow access rights for Gilead on 15 programs …
Read More »